Echinocandins: are they all the same? (Q37974743)

26 August 2017

Echinocandins: are they all the same? (English)

1 reference

26 August 2017

Mukherjee PK

1

1 reference

26 August 2017

Sheehan D

2

1 reference

26 August 2017

Puzniak L

3

1 reference

26 August 2017

Schlamm H

4

1 reference

26 August 2017

Ghannoum MA

5

1 reference

26 August 2017

language of work or name

1 reference

1 December 2011

1 reference

26 August 2017

Journal of Chemotherapy

1 reference

26 August 2017

23

1 reference

26 August 2017

6

1 reference

26 August 2017

319-325

1 reference

Anidulafungin: a new echinocandin for candidal infections

26 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Antifungal agents: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Significant differences in drug susceptibility among species in the Candida parapsilosis group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Influence of human serum on antifungal pharmacodynamics with Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Studies of the paradoxical effect of caspofungin at high drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vitro activity of anidulafungin against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

What distinctions do Candida biofilms have to offer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.6.319

10.1179/JOC.2011.23.6.319

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference